AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

CONMED Corp Director's Dealing 2025

Feb 26, 2025

31971_dirs_2025-02-26_4c0008b1-867a-414f-a033-a73ee1c2fe42.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: CONMED Corp (CNMD)
CIK: 0000816956
Period of Report: 2025-02-24

Reporting Person: Kaye Mark (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	0	Direct

Footnotes

F1: Remarks: Mark Kaye became a Director of Conmed on February 24, 2025